Let’s Talk Respiratory is an educational platform of supportive resources, materials and the latest CPD learning in respiratory care, initiated and funded by Teva UK Limited. Due to the varied breadth and nature of topics on Let’s Talk Respiratory, drug classes and guidance related to Teva’s products may be mentioned. Adverse events reporting and links to relevant prescribing information can be found at the bottom of the page.

About us

Let’s Talk Respiratory aims to support and enhance patient care across the full spectrum of management, from primary through to tertiary care. Content is developed in collaboration with an editorial board of multidisciplinary healthcare professionals working across respiratory care. The editorial board provide expert input into the site content and work alongside the dedicated Let’s Talk Respiratory editorial team to identify key respiratory topics and learning needs in asthma, including severe asthma, COPD and cystic fibrosis.


Let’s Talk Respiratory can help towards your yearly CPD requirements for appraisal and revalidation, with each high-quality educational article allocated a suggested number of hours of CPD. To see how many CPD hours an article is worth, look for the star with a number next to it (0.5 or 1.0).

The CPD recommendation is based on time spent on the activity and the associated reflection on learning. If you spend less time, we recommend claiming fewer credits.

Editorial board members

Editorial board members help to develop the content, topics and articles on Let’s Talk Respiratory.

Dr Steve Holmes is a GP partner in Shepton Mallet, Somerset and a GP trainer. He is a previous chair of the Primary Care Respiratory Society and is currently its education lead.

Steve has been involved in working on a number of national guidelines and policies and is an experienced writer and presenter. He is passionate about encouraging high quality care care for our patients.

Dr Richard Russell is a Consultant Respiratory Physician at Southern Health NHS Foundation Trust, Clinical Director of the West Hampshire Integrated Respiratory Service, and is a Senior Researcher at the University of Oxford.

Richard is interested in all respiratory disease, but particularly in COPD and asthma. He is Editor in Chief of the International Journal of COPD, is a peer reviewer for several journals and a regular presenter.

Ravijyot Saggu is Lead Clinical Pharmacist for Medicine and Emergency Services, with a respiratory specialism and interest in ILD and airways disease (including severe asthma), at University College Hospital in London, and an Honorary Clinical Lecturer for UCL School of Pharmacy. She is Chair of the UK Clinical Pharmacy Association Respiratory Group.

Ravijyot has been involved with developing guidelines for the British Thoracic Society and NICE, as well as producing educational learning material for pharmacists about asthma and COPD.

Jane Scullion is a Respiratory Nurse Consultant at the University Hospitals of Leicester and a member of the East Midlands Clinical Senate, Director of Education for UUKIG and member of ADMIT.

She works across primary and secondary care and has a particular interest in chronic respiratory disease, including difficult asthma, COPD and interstitial lung disease. Jane is widely published and is a member of the editorial board of Thorax and Primary Health Care.

Professor Dominick Shaw is Honorary Consultant at Nottingham University, and Severe Asthma Lead at the National Institute for Health Research, Nottingham Respiratory Biomedical Research Centre.

Content development

Content for Let’s Talk Respiratory is regularly updated to bring you the latest in respiratory care. Editorial board members identify educational needs and suggest hot topics across all areas. They recommend experts in the field to provide interesting, informative content.

All articles are put through a rigorous quality control process by the Let’s Talk Respiratory editorial team at Haymarket Media Group before being reviewed by the editorial board ahead of final checks and publication on the site.

Haymarket Media Group produces content for Let’s Talk Respiratory on behalf of Teva UK Ltd. 

Approval code: RESP-GB-00568 Date of preparation: June 2022